Kinnate Biopharma Inc. Quarterly Operating Leases, Future Minimum Payments, Due in Three Years in USD from Q4 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
Summary
Kinnate Biopharma Inc. quarterly Operating Leases, Future Minimum Payments, Due in Three Years history and growth rate from Q4 2021 to Q4 2022.
  • Kinnate Biopharma Inc. Operating Leases, Future Minimum Payments, Due in Three Years for the quarter ending December 31, 2022 was $1.08M, unchanged year-over-year.
Operating Leases, Future Minimum Payments, Due in Three Years, Quarterly (USD)
Operating Leases, Future Minimum Payments, Due in Three Years, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $1.08M $0 0% Dec 31, 2022 10-K 2023-03-15
Q4 2021 $1.08M Dec 31, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.